2591.HK

Guangzhou Innogen Pharmaceutl Grp Co Ltd 2591.HK

Finances

2024 2023
Revenue 0.000 0.000
Net income -174.690 M 76.18 % -733.376 M
Income before tax -174.690 M 76.18 % -733.376 M
Income before tax ratio 0.00 0.00
EBITDA -156.894 M 77.95 % -711.422 M
Net income ratio 0.00 0.00
Ratio EBITDA 0.00 0.00
Gross profit ratio 0.00 0.00
Weighted average shs out dil 456.819 M 0.00 % 456.819 M
Weighted average shs out 456.819 M 0.00 % 456.819 M
EPS diluted -0.38 76.40 % -1.61
Earnings per share -0.38 76.40 % -1.61
Gross profit 0.000 0.000
Income tax expense 0.000 0.000
Cost of revenue 0.000 0.000
General and administrative expenses 37.819 M 233.56 % 11.338 M
Selling and marketing expenses 2.386 M 0.000
Other expenses 46.691 M -80.82 % 243.394 M
Operating expenses 189.407 M -74.64 % 746.840 M
Cost and expenses 189.407 M -74.64 % 746.840 M
Research and development expenses 102.511 M -79.17 % 492.108 M
Selling general and administrative expenses 40.205 M 254.60 % 11.338 M
Interest income 3.822 M -8.80 % 4.191 M
Interest expense 873.000 K -62.34 % 2.318 M
Depreciation and amortization 16.923 M -13.82 % 19.636 M
Operating income 0.000 0.000
Operating income ratio 0.00 0.00
Total other income expenses net -174.690 M 76.18 % -733.376 M
2024 2023
2024 2023
Net debt -516.641 M -43.08 % -361.084 M
Total investments 270.339 M -49.72 % 537.671 M
Total debt 9.900 M -78.75 % 46.586 M
Accumulated other comprehensive income loss 0.000 0.000
Retained earnings -1.497 B -13.21 % -1.323 B
Common stock 420.263 M 5.68 % 397.668 M
Total equity 796.471 M 12.95 % 705.125 M
Other non current liabilities 72.000 K -1.37 % 73.000 K
Long term debt 0.000 -100.00 % 40.762 M
Total non current liabilities 72.000 K -99.82 % 40.835 M
Other current liabilities 36.599 M -86.15 % 264.292 M
Deferred revenue 0.000 0.000
Short term debt 9.900 M 69.99 % 5.824 M
Total current liabilities 138.257 M -61.53 % 359.404 M
Total liabilities 138.329 M -65.44 % 400.239 M
Other non current assets 58.191 M 1.79 % 57.167 M
Long term investments 0.000 0.000
Intangible assets 24.094 M -32.83 % 35.868 M
GoodWill 0.000 0.000
Goodwill and intangible assets 24.094 M -32.83 % 35.868 M
Property plant equipment net 13.300 M -75.75 % 54.854 M
Total non current assets 95.585 M -35.37 % 147.889 M
Other current assets 13.300 M 53.14 % 8.685 M
Short term investments 270.339 M -49.72 % 537.671 M
cash and cash equivalents 526.541 M 29.16 % 407.670 M
Cash and short term investments 796.880 M -15.70 % 945.341 M
Total current assets 839.215 M -12.35 % 957.475 M
Inventory 29.035 M 741.84 % 3.449 M
Net receivables 0.000 0.000
Tax assets 0.000 0.000
Other assets 0.000 0.000
Account payables 91.045 M 3.07 % 88.333 M
Tax payables 713.000 K -25.34 % 955.000 K
Deferred revenue non current 0.000 0.000
Minority interest 0.000 0.000
Capital lease obligations 0.000 -100.00 % 45.586 M
Preferred stock 0.000 0.000
Other total stockholders equity 1.873 B 14.93 % 1.630 B
Deferred tax liabilities non current 0.000 0.000
Other liabilities 0.000 0.000
Total assets 934.800 M -15.43 % 1.105 B
2024 2023
2024 2023
Deferred income tax 0.000 0.000
Stock based compensation 16.036 M -97.02 % 538.904 M
Change in working capital -8.412 M -142.51 % 19.790 M
Accounts receivables 0.000 0.000
Inventory -25.586 M -11 224.35 % 230.000 K
Accounts payables 0.000 0.000
Other working capital 17.174 M -12.20 % 19.560 M
Other non cash items -12.476 M -30.63 % -9.551 M
Net cash provided by operating activities -162.619 M 1.20 % -164.597 M
Investments in property plant and equipment -3.950 M 67.21 % -12.045 M
Acquisitions net 0.000 0.000
Purchases of investments -5.021 B -12.81 % -4.451 B
Sales maturities of investments 5.301 B 23.12 % 4.306 B
Other investing activites -379.000 K -159.59 % -146.000 K
Net cash used for investing activites 275.954 M 275.53 % -157.208 M
Debt repayment 8.900 M 0.000
Common stock issued 250.000 M -32.03 % 367.814 M
Common stock repurchased 0.000 0.000
Dividends paid 0.000 0.000
Other financing activites -4.061 M 74.79 % -16.108 M
Net cash used provided by financing activities 254.839 M -27.54 % 351.706 M
Effect of forex changes on cash 697.000 K -1.13 % 705.000 K
Net change in cash 368.871 M 1 105.22 % 30.606 M
Cash at beginning of period 157.640 M 24.09 % 127.034 M
Cash at end of period 526.511 M 234.00 % 157.640 M
Operating cash flow -162.619 M 1.20 % -164.597 M
Capital expenditure -4.329 M 64.49 % -12.191 M
Free CashFlow -166.948 M 5.57 % -176.788 M
2024 2023
Revenue
Net income
Income before tax
Income before tax ratio
EBITDA
Net income ratio
Ratio EBITDA
Gross profit ratio
Weighted average shs out dil
Weighted average shs out
EPS diluted
Earnings per share
Gross profit
Income tax expense
Cost of revenue
General and administrative expenses
Selling and marketing expenses
Other expenses
Operating expenses
Cost and expenses
Research and development expenses
Selling general and administrative expenses
Interest income
Interest expense
Depreciation and amortization
Operating income
Operating income ratio
Total other income expenses net
2025-05-31
Net debt -525.157 M
Total investments 175.805 M
Total debt 31.537 M
Accumulated other comprehensive income loss 0.000
Retained earnings -1.595 B
Common stock 420.263 M
Total equity 705.373 M
Other non current liabilities 72.000 K
Long term debt 14.774 M
Total non current liabilities 14.846 M
Other current liabilities 42.510 M
Deferred revenue 0.000
Short term debt 16.763 M
Total current liabilities 187.472 M
Total liabilities 202.318 M
Other non current assets 24.608 M
Long term investments 0.000
Intangible assets 24.110 M
GoodWill 0.000
Goodwill and intangible assets 24.110 M
Property plant equipment net 32.422 M
Total non current assets 81.140 M
Other current assets 0.000
Short term investments 175.805 M
cash and cash equivalents 556.694 M
Cash and short term investments 732.499 M
Total current assets 826.551 M
Inventory 32.830 M
Net receivables 61.222 M
Tax assets 0.000
Other assets 0.000
Account payables 127.593 M
Tax payables 606.000 K
Deferred revenue non current 0.000
Minority interest 0.000
Capital lease obligations 16.880 M
Preferred stock 0.000
Other total stockholders equity 1.880 B
Deferred tax liabilities non current 0.000
Other liabilities 0.000
Total assets 907.691 M
2025-05-31
Deferred income tax
Stock based compensation
Change in working capital
Accounts receivables
Inventory
Accounts payables
Other working capital
Other non cash items
Net cash provided by operating activities
Investments in property plant and equipment
Acquisitions net
Purchases of investments
Sales maturities of investments
Other investing activites
Net cash used for investing activites
Debt repayment
Common stock issued
Common stock repurchased
Dividends paid
Other financing activites
Net cash used provided by financing activities
Effect of forex changes on cash
Net change in cash
Cash at beginning of period
Cash at end of period
Operating cash flow
Capital expenditure
Free CashFlow